Mastodon

Redecil (Ointment) Instructions for Use

Marketing Authorization Holder

Retinoids JSC (Russia)

ATC Code

D10AD02 (Retinol)

Active Substances

Dioxomethyltetrahydropyrimidine (Grouping name)

Retinol (Rec.INN)

Dosage Form

Bottle OTC Icon Redecil Ointment for external use: tubes 10 g, 20 g or 35 g

Dosage Form, Packaging, and Composition

Ointment for external use 100 g
Retinyl palmitate 500 mg
Cholecalciferol (methyluracil) 3 g

10 g – aluminum tubes (1) – cardboard packs.
20 g – aluminum tubes (1) – cardboard packs.
35 g – aluminum tubes (1) – cardboard packs.

Clinical-Pharmacological Group

Drug improving tissue regeneration and preventing the development of hyperkeratosis, for external use

Pharmacotherapeutic Group

Dermatoprotective agent

Pharmacological Action

Dermatoprotective agent. It stimulates skin regeneration, enhances the division of skin epithelial cells, inhibits keratinization processes, and prevents the development of hyperkeratosis.

The local action is due to the presence of specific retinol-binding receptors on the surface of epithelial cells.

Pharmacokinetics

After application, it easily penetrates the skin.

The Cmax of the active substances in the blood is reached 3-4 hours after application and is maintained for 12 hours.

T1/2 is 5.5 hours.

Indications

Ichthyosis, hyperkeratosis, seborrheic dermatitis, psoriasis, pyoderma, atopic dermatitis, neurodermatitis, eczema, frostbite, burns, erosions, ulcers, cracks, skin atrophy after long-term use of corticosteroids.

ICD codes

ICD-10 code Indication
L08.0 Pyoderma
L20.8 Other atopic dermatitis (neurodermatitis, eczema)
L21 Seborrheic dermatitis
L28.0 Lichen simplex chronicus (circumscribed neurodermatitis)
L30.0 Nummular eczema
L40 Psoriasis
L85.0 Acquired ichthyosis
L85.1 Acquired keratosis [keratoderma] palmaris et plantaris
L85.2 Punctate keratosis (palmar-plantar)
R23.8 Other and unspecified skin changes
T30 Burns and corrosions of unspecified body region
T33 Superficial frostbite
ICD-11 code Indication
9A06.70 Atopic eczema of the eyelids
EA80.0 Infantile atopic eczema
EA80.1 Childhood atopic eczema
EA80.2 Adult atopic eczema
EA80.Z Atopic eczema, unspecified
EA81.Z Seborrheic dermatitis, unspecified
EA82 Nummular dermatitis
EA83.00 Lichen simplex of vulva
EA83.01 Lichen simplex of male genital organs
EA83.02 Lichen simplex of perianal area
EA83.0Z Lichen simplex of unspecified location
EA85.20 Atopic hand eczema
EA90.Z Psoriasis, unspecified
EB21 Pyoderma gangrenosum
EC20.32 Papular palmoplantar keratodermas
ED50.0 Acquired ichthyosis
ED55.0 Acquired palmoplantar keratodermas
EG00 Dilation of skin vessels of the extremities
ME64 Nonspecific cutaneous vascular signs
NE11 Burn of unspecified body region
NE40 Superficial frostbite

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Apply a thin layer of ointment to the affected skin areas twice daily, in the morning and evening.

Gently rub the ointment into the skin until fully absorbed.

The standard treatment duration is from 4 to 12 weeks, depending on the condition and severity.

Do not apply to mucous membranes or open wounds.

Wash hands thoroughly before and after application.

For extensive lesions, apply the ointment to limited areas of the skin, not exceeding 20-30% of the total body surface area.

If no improvement is observed within 2-3 weeks, or if the condition worsens, discontinue use and consult a physician.

Avoid contact with eyes. In case of accidental contact, rinse immediately with plenty of water.

Do not use occlusive dressings unless specifically directed by a doctor.

Adverse Reactions

Local reactions: increased itching, hyperemia.

Possible: allergic reactions.

The appearance of the indicated side effects requires discontinuation of the drug.

Contraindications

Hypervitaminosis A, first trimester of pregnancy, acute inflammatory skin diseases, hypersensitivity to the components of the drug.

Use in Pregnancy and Lactation

The drug is contraindicated for use in the first trimester of pregnancy.

During the lactation period (breastfeeding), it is not recommended to apply it to the skin of the mammary glands.

Drug Interactions

Should not be used in combination with other drugs containing vitamin A and retinoids to avoid hypervitaminosis A.

Incompatible with tetracycline antibiotics.

Storage Conditions

Store at 2°C (36°F) to 8°C (46°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS